597 related articles for article (PubMed ID: 34424997)
1. SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function.
Brunk F; Moritz A; Nelde A; Bilich T; Casadei N; Fraschka SAK; Heitmann JS; Hörber S; Peter A; Rammensee HG; Singh H; Walz J; Maurer D; Wagner C
Eur J Immunol; 2021 Nov; 51(11):2651-2664. PubMed ID: 34424997
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of highly cytotoxic CD8
Wagner KI; Mateyka LM; Jarosch S; Grass V; Weber S; Schober K; Hammel M; Burrell T; Kalali B; Poppert H; Beyer H; Schambeck S; Holdenrieder S; Strötges-Achatz A; Haselmann V; Neumaier M; Erber J; Priller A; Yazici S; Roggendorf H; Odendahl M; Tonn T; Dick A; Witter K; Mijočević H; Protzer U; Knolle PA; Pichlmair A; Crowell CS; Gerhard M; D'Ippolito E; Busch DH
Cell Rep; 2022 Jan; 38(2):110214. PubMed ID: 34968416
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.
Dykema AG; Zhang B; Woldemeskel BA; Garliss CC; Cheung LS; Choudhury D; Zhang J; Aparicio L; Bom S; Rashid R; Caushi JX; Hsiue EH; Cascino K; Thompson EA; Kwaa AK; Singh D; Thapa S; Ordonez AA; Pekosz A; D'Alessio FR; Powell JD; Yegnasubramanian S; Zhou S; Pardoll DM; Ji H; Cox AL; Blankson JN; Smith KN
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33830946
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.
Shomuradova AS; Vagida MS; Sheetikov SA; Zornikova KV; Kiryukhin D; Titov A; Peshkova IO; Khmelevskaya A; Dianov DV; Malasheva M; Shmelev A; Serdyuk Y; Bagaev DV; Pivnyuk A; Shcherbinin DS; Maleeva AV; Shakirova NT; Pilunov A; Malko DB; Khamaganova EG; Biderman B; Ivanov A; Shugay M; Efimov GA
Immunity; 2020 Dec; 53(6):1245-1257.e5. PubMed ID: 33326767
[TBL] [Abstract][Full Text] [Related]
6. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.
Wu D; Kolesnikov A; Yin R; Guest JD; Gowthaman R; Shmelev A; Serdyuk Y; Dianov DV; Efimov GA; Pierce BG; Mariuzza RA
Nat Commun; 2022 Jan; 13(1):19. PubMed ID: 35013235
[TBL] [Abstract][Full Text] [Related]
7. Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection.
Wang Y; Duan F; Zhu Z; Yu M; Jia X; Dai H; Wang P; Qiu X; Lu Y; Huang J
Cells; 2021 Dec; 11(1):. PubMed ID: 35011632
[TBL] [Abstract][Full Text] [Related]
8. HLA-A
Nesterenko PA; McLaughlin J; Tsai BL; Burton Sojo G; Cheng D; Zhao D; Mao Z; Bangayan NJ; Obusan MB; Su Y; Ng RH; Chour W; Xie J; Li YR; Lee D; Noguchi M; Carmona C; Phillips JW; Kim JT; Yang L; Heath JR; Boutros PC; Witte ON
Cell Rep; 2021 Dec; 37(13):110167. PubMed ID: 34919800
[TBL] [Abstract][Full Text] [Related]
9. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.
Mahajan S; Kode V; Bhojak K; Karunakaran C; Lee K; Manoharan M; Ramesh A; Hv S; Srivastava A; Sathian R; Khan T; Kumar P; Gupta R; Chakraborty P; Chaudhuri A
Sci Rep; 2021 Jun; 11(1):13164. PubMed ID: 34162945
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nelde A; Bilich T; Heitmann JS; Maringer Y; Salih HR; Roerden M; Lübke M; Bauer J; Rieth J; Wacker M; Peter A; Hörber S; Traenkle B; Kaiser PD; Rothbauer U; Becker M; Junker D; Krause G; Strengert M; Schneiderhan-Marra N; Templin MF; Joos TO; Kowalewski DJ; Stos-Zweifel V; Fehr M; Rabsteyn A; Mirakaj V; Karbach J; Jäger E; Graf M; Gruber LC; Rachfalski D; Preuß B; Hagelstein I; Märklin M; Bakchoul T; Gouttefangeas C; Kohlbacher O; Klein R; Stevanović S; Rammensee HG; Walz JS
Nat Immunol; 2021 Jan; 22(1):74-85. PubMed ID: 32999467
[TBL] [Abstract][Full Text] [Related]
11. CD8
Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
Front Immunol; 2021; 12():764949. PubMed ID: 35116022
[TBL] [Abstract][Full Text] [Related]
12. Detection of IFNγ-Secreting CD4
Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
[TBL] [Abstract][Full Text] [Related]
13. CD8
Nguyen THO; Rowntree LC; Petersen J; Chua BY; Hensen L; Kedzierski L; van de Sandt CE; Chaurasia P; Tan HX; Habel JR; Zhang W; Allen LF; Earnest L; Mak KY; Juno JA; Wragg K; Mordant FL; Amanat F; Krammer F; Mifsud NA; Doolan DL; Flanagan KL; Sonda S; Kaur J; Wakim LM; Westall GP; James F; Mouhtouris E; Gordon CL; Holmes NE; Smibert OC; Trubiano JA; Cheng AC; Harcourt P; Clifton P; Crawford JC; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Torresi J; Kedzierska K
Immunity; 2021 May; 54(5):1066-1082.e5. PubMed ID: 33951417
[TBL] [Abstract][Full Text] [Related]
14. Identification of HLA-A2 restricted CD8
Deng J; Pan J; Qiu M; Mao L; Wang Z; Zhu G; Gao L; Su J; Hu Y; Luo OJ; Chen G; Wang P
J Leukoc Biol; 2021 Dec; 110(6):1171-1180. PubMed ID: 34231935
[TBL] [Abstract][Full Text] [Related]
15. PD-1-Expressing SARS-CoV-2-Specific CD8
Rha MS; Jeong HW; Ko JH; Choi SJ; Seo IH; Lee JS; Sa M; Kim AR; Joo EJ; Ahn JY; Kim JH; Song KH; Kim ES; Oh DH; Ahn MY; Choi HK; Jeon JH; Choi JP; Kim HB; Kim YK; Park SH; Choi WS; Choi JY; Peck KR; Shin EC
Immunity; 2021 Jan; 54(1):44-52.e3. PubMed ID: 33338412
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2-specific CD8
Rowntree LC; Petersen J; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Wheatley AK; Kent SJ; Rossjohn J; Kedzierska K; Nguyen TH
Immunol Cell Biol; 2021 Oct; 99(9):990-1000. PubMed ID: 34086357
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ
Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
[TBL] [Abstract][Full Text] [Related]
18. Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles.
Becerra-Artiles A; Calvo-Calle JM; Co MD; Nanaware PP; Cruz J; Weaver GC; Lu L; Forconi C; Finberg RW; Moormann AM; Stern LJ
Cell Rep; 2022 Jun; 39(11):110952. PubMed ID: 35675811
[TBL] [Abstract][Full Text] [Related]
19. Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
Kim N; Lee JM; Oh EJ; Jekarl DW; Lee DG; Im KI; Cho SG
Front Immunol; 2021; 12():751869. PubMed ID: 35003063
[TBL] [Abstract][Full Text] [Related]
20. Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein.
Zhang Y; Yang Z; Tang M; Li H; Tang T; Li G; Zhong Y; Zhang X; Wang X; Wang C
Front Immunol; 2022; 13():752622. PubMed ID: 35154095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
